PDF herunterladen
Thromb Haemost
DOI: 10.1055/a-2633-0069
Letter to the Editor

Left Atrial Appendage Closure after Ablation for Atrial Fibrillation: A Real-World Propensity Score-Matched Study

Laurent Fauchier 
1   Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, Tours, France
,
Lisa Lochon
1   Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, Tours, France
,
Thibault Lenormand
1   Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, Tours, France
,
Bertrand Pierre
1   Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, Tours, France
,
Arnaud Bisson
1   Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, Tours, France
› Institutsangaben
› Weitere Informationen
   Lizenzen und Reprints


Data Availability Statement

To gain access to the data in the TriNetX research network, requests are directed to TriNetX and a data-sharing agreement is required.


Ethical Approval Statement

As the study was conducted retrospectively and patients were not directly involved in its conduct, there was no impact on their care. Ethical approval was not required, as all data were anonymized.


Authors' Contribution

L.F. drafted the manuscript. All authors contributed equally to the conception and critical revision of this letter. All authors approved the final version of the manuscript.




Publikationsverlauf

Eingereicht: 03. Mai 2025

Angenommen: 11. Juni 2025

Accepted Manuscript online:
12. Juni 2025

Artikel online veröffentlicht:
20. Juni 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • References

  • 1 Wazni OM, Saliba WI, Nair DG. et al. Left atrial appendage closure after ablation for atrial fibrillation. N Engl J Med 2025; 392 (13) 1277-1287
    PubMedSuche in Google Scholar
  • 2 Acton EK, Hennessy S, Gelfand MA. et al. Direct-acting oral anticoagulants and antiseizure medications for atrial fibrillation and epilepsy and risk of thromboembolic events. JAMA Neurol 2024; 81 (08) 835-844
    PubMedSuche in Google Scholar
  • 3 Aglan A, Fath AR, Maron BJ. et al. Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation. Heart Rhythm 2024; 21 (09) 1677-1683
    PubMedSuche in Google Scholar
  • 4 Van Gelder IC, Rienstra M, Bunting KV. et al; ESC Scientific Document Group. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2024; 45 (36) 3314-3414
    CrossrefPubMedSuche in Google Scholar
  • 5 Turagam MK, Osmancik P, Neuzil P, Dukkipati SR, Reddy VY. Left atrial appendage closure versus oral anticoagulants in atrial fibrillation: a meta-analysis of randomized trials. J Am Coll Cardiol 2020; 76 (23) 2795-2797
    CrossrefPubMedSuche in Google Scholar
  • 6 Fauchier L, Cinaud A, Brigadeau F. et al. Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol 2018; 71 (14) 1528-1536
    PubMedSuche in Google Scholar
  • 7 Willits I, Keltie K, Linker N. et al. Left atrial appendage occlusion in the UK: prospective registry and data linkage to Hospital Episode Statistics. Eur Heart J Qual Care Clin Outcomes 2021; 7 (05) 468-475
    PubMedSuche in Google Scholar
  • 8 Aminian A, De Backer O, Nielsen-Kudsk JE. et al. Incidence and clinical impact of major bleeding following left atrial appendage occlusion: insights from the Amplatzer Amulet Observational Post-Market Study. EuroIntervention 2021; 17 (09) 774-782
    PubMedSuche in Google Scholar
  • 9 Geisler T, Jorbenadze R, Popov AF. et al. Thrombogenicity and antithrombotic strategies in structural heart interventions and nonaortic cardiac device therapy-current evidence and practice. Thromb Haemost 2019; 119 (10) 1590-1605
    PubMedSuche in Google Scholar
  • 10 Potpara T, Romiti GF, Sohns C. The 2024 European Society of Cardiology Guidelines for diagnosis and management of atrial fibrillation: a viewpoint from a practicing clinician's perspective. Thromb Haemost 2024; 124 (12) 1087-1094
    Thieme ConnectPubMedSuche in Google Scholar
  • 11 Potpara T, Grygier M, Häusler KG. et al. Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper. Europace 2024; 26 (04) euae035
    CrossrefPubMedSuche in Google Scholar
  • 12 Hindricks G, Potpara T, Dagres N. et al; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021; 42 (05) 373-498
    CrossrefPubMedSuche in Google Scholar
  • 13 Joglar JA, Chung MK, Armbruster AL. et al; Writing Committee Members. 2023 ACC/AHA/ACCP/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2024; 83 (01) 109-279
    CrossrefPubMedSuche in Google Scholar